+629.1%
MRNA vs TRMB
+56.2%
+572.9%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | TRMB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -2.3% | -1.0% | -2.4% |
| 7D | -10.1% | -2.9% | -7.2% | -8.9% |
| 30D | +126.7% | -1.8% | +128.5% | +129.3% |
| 3M | +184.1% | +8.4% | +175.7% | +175.6% |
| 6M | +143.3% | -18.5% | +161.8% | +162.0% |
| YTD | +359.9% | -26.7% | +386.6% | +413.8% |
| 1Y | +454.2% | -28.3% | +482.5% | +524.7% |
| 3Y | +26.0% | +12.6% | +13.4% | +21.1% |
| 5Y | -70.3% | -38.7% | -31.5% | -67.9% |
| All | +629.1% | +56.2% | +572.9% | +698.6% |
Cumulative growth
Daily Returns
Daily percentage return beside TRMB.
Daily Out/Under-Performance
Portfolio return minus TRMB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × TRMB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded TRMB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling